H.C. Wainwright Remains a Buy on Inventiva (IVA)
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Inventiva (IVA – Research Report), with a price target...
Source: businessinsider.com
Page 5 - Ed Arce News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ed Arce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ed Arce Today - Breaking & Trending Today
Microsoft To Rally Around 16%? Here Are 10 Other Analyst Forecasts For Tuesday - Camtek (NASDAQ:CAMT), Casey's General Stores (NASDAQ:CASY)
B of A Securities boosted the price target for Camtek Ltd. (NASDAQ: CAMT) from $30 to $50. B of A Securities analyst Vivek Arya upgraded the stock from Neutral to Buy. Camtek shares rose 1.8% to $44.02 in pre-market trading.
Source: benzinga.com
Positive Report for Intercept Pharma (ICPT) from H.C. Wainwright
Intercept Pharma (ICPT – Research Report) received a Buy rating and a $19.00 price target from H.C. Wainwright analyst Ed Arce today. The ...
Source: businessinsider.com
Approval Sought in Japan for New SARS-CoV-2 Vaccine
Approval Sought in Japan for New SARS-CoV-2 Vaccine
Source: investorideas.com
Why Shares of CymaBay Therapeutics Are Soaring Friday
A competitor's drug had a so-so phase 3 trial, lifting the possibilities for CymaBay's lead therapy.
Source: fool.com